Literature DB >> 26917907

Contrast-enhanced fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography in mediastinal T-cell lymphoma with superior vena cava syndrome.

Sampath Santhosh1, Arun Kumar Reddy Gorla1, Anish Bhattacharya1, Subhash Chander Varma2, Bhagwant Rai Mittal1.   

Abstract

Positron emission tomography-computed tomography (PET/CT) is a routine investigation for the staging of lymphomas. Contrast-enhanced computed tomography is mandatory whenever parenchymal lesions, especially in the liver and spleen are suspected. We report a rare case of primary mediastinal T-cell lymphoma evaluated with contrast-enhanced PET/CT that showed features of superior vena cava syndrome.

Entities:  

Keywords:  Fluorodeoxyglucose; non-Hodgkin's lymphoma; positron emission tomography/contrast-enhanced computed tomography; primary mediastinal lymphoma; superior vena cava syndrome

Year:  2016        PMID: 26917907      PMCID: PMC4746854          DOI: 10.4103/0972-3919.172374

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


A 28-year-old male patient presented with a history of a dry cough for a year and neck swelling (1-month). Multiple large mediastinal lymph nodes were detected on computed tomography (CT) of the thorax. Biopsy suggested T-cell lymphoblastic lymphoma (LBL) type of non-Hodgkin's lymphoma (NHL). Contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced CT (FDG PET/CECT) was done for initial staging. Maximum intensity projection [Figure 1a] and coronal fused PET/CT [Figure 1b] images showed an intensely FDG-avid (SUVma × 12.0) heterogeneously enhancing conglomerate nodal mass measuring 15.3 cm × 14.2 cm × 13.5 cm with central necrosis (arrow) in the superior mediastinum and right hemithorax, extending from the D3–D9 vertebrae, with collapse of the upper lobe of the right lung. Physiological FDG uptake was seen in the marrow and rest of the visualized organs. The axial CECT image [Figure 1c] showed the lesion encasing the right main bronchus causing left mediastinal shift, displacing and compressing the right brachiocephalic vein, distal azygous vein and superior vena cava (SVC) (arrows). An axial CECT image at a higher level (d) showed multiple collateral veins in the subcutaneous plane in the anterior thoracic and abdominal wall bilaterally (right >left) and right upper limb. A volume-rendered image (e) clearly depicted the subcutaneous collaterals (arrows), suggesting SVC obstruction. A bone marrow biopsy was negative for lymphomatous infiltration. The final diagnosis was Stage I (X) NHL with SVC syndrome.
Figure 1

Maximum intensity projection (a) and coronal fused positron emission tomography-computed tomography (b) images showed an intensely fluorodeoxyglucose-avid heterogeneously enhancing conglomerate nodal mass with central necrosis (arrow) in the superior mediastinum and right hemithorax. The axial contrast-enhanced computed tomography image (c) the lesion compressing the distal azygous vein and superior vena cava (arrows). An axial contrast-enhanced computed tomography image at a higher level (d) multiple collateral veins in subcutaneous plane in the anterior thoracic wall bilaterally. A volume-rendered image (e) clearly depicted the subcutaneous collaterals (arrows), suggesting superior vena cava obstruction

Maximum intensity projection (a) and coronal fused positron emission tomography-computed tomography (b) images showed an intensely fluorodeoxyglucose-avid heterogeneously enhancing conglomerate nodal mass with central necrosis (arrow) in the superior mediastinum and right hemithorax. The axial contrast-enhanced computed tomography image (c) the lesion compressing the distal azygous vein and superior vena cava (arrows). An axial contrast-enhanced computed tomography image at a higher level (d) multiple collateral veins in subcutaneous plane in the anterior thoracic wall bilaterally. A volume-rendered image (e) clearly depicted the subcutaneous collaterals (arrows), suggesting superior vena cava obstruction SVC syndrome is caused by obstruction of the SVC either by extrinsic compression or internal thrombus. Clinical signs include cyanosis, plethora distention of subcutaneous vessels, and edema of the arms, head and neck. Edema may compromise the function of the larynx or pharynx causing dyspnea, stridor, cough, hoarseness, and dysphagia. Cerebral edema can occur as serious sequelae causing headaches, confusion, and possibly coma.[1] SVC syndrome is most commonly associated with metastatic pulmonary or mediastinal malignancy.[2] Benign causes include infection, idiopathic mediastinal fibrosis, retrosternal thyroid, aortic aneurysm, benign tumors, mediastinal hematoma, sarcoidosis, radiation fibrosis, and iatrogenic causes like thrombosis of the SVC following central venous catheter placement.[3] Our patient presented with a cough and there was distention of subcutaneous vessels in the neck on the right side with imaging findings of SVC obstruction caused by compression of SVC by enlarged mediastinal nodal T-cell lymphoma. LBL is a rare form of aggressive NHL, occurring in 1–2% of all NHLs.[4] T-cell LBL is typically seen in adolescence and young adults with a nearly three-fold male predominance. It presents with a mediastinal mass in 60–70% of the cases.[5] On the other hand, about 10% of lymphomas involving the mediastinum are primary, of which T-cell LBL is very rare.[67] In the NHL Classification Project, only 13% T-cell LBLs had Stages 1 or 2 disease.[4] Patients with T-cell LBL often present with shortness of breath due to either compression of the SVC or pleural or pericardial effusion.[89] The azygous-hemiazygous is the common collateral pathway that predominates in SVC obstruction; however, the internal-external mammary and lateral thoracic pathways were involved as collaterals in our case due to additional azygous vein obstruction.[3] Other unusual collateral pathways that may be seen with SVC obstruction include systemic-to-pulmonary venous pathway causing right to left shunt and cavoportal pathway causing unusual enhancement patterns in the liver.[3] PET/CT has been used for staging other types of mediastinal lymphomas.[1011] This case highlights the role of PET/CT in staging a rare type of primary mediastinal T-cell NHL and suggests that contrast-enhanced FDG-PET/CT may be a useful investigation for the evaluation of mediastinal lymphoma with suspicion of SVC syndrome.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  11 in total

Review 1.  Lymphoblastic lymphoma.

Authors:  Sergio Cortelazzo; Maurilio Ponzoni; Andrés J M Ferreri; Dieter Hoelzer
Journal:  Crit Rev Oncol Hematol       Date:  2011-01-26       Impact factor: 6.312

Review 2.  Superior vena cava syndrome--a proposed classification system and algorithm for management.

Authors:  James B Yu; Lynn D Wilson; Frank C Detterbeck
Journal:  J Thorac Oncol       Date:  2008-08       Impact factor: 15.609

Review 3.  Mediastinal lymphomas--differential diagnosis.

Authors:  Biljana Mihaljević; Ljubomir Jaković; Snezana Janković; Maja Perunicić Jovanović; Violeta Milosević; Bosko Andelić; Aleksandra Sretenović; Milan Petrović
Journal:  Vojnosanit Pregl       Date:  2008-02       Impact factor: 0.168

4.  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

Authors: 
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

Review 5.  Tumors of the mediastinum.

Authors:  Beau V Duwe; Daniel H Sterman; Ali I Musani
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

6.  Where there is blood, there is a way: unusual collateral vessels in superior and inferior vena cava obstruction.

Authors:  Sangita Kapur; Eugene Paik; Ario Rezaei; Doan N Vu
Journal:  Radiographics       Date:  2010-01       Impact factor: 5.333

7.  A rare case of primary thymic Hodgkin lymphoma in an elderly patient detected by 18F-FDG PET/CT.

Authors:  Giorgio Treglia; Filippo Lococo; Gianluigi Petrone; Antonella Stefanelli; Giulia Carnassale; Maria Lucia Calcagni; Pierluigi Granone; Alessandro Giordano
Journal:  Clin Nucl Med       Date:  2013-05       Impact factor: 7.794

Review 8.  Adult lymphoblastic lymphoma.

Authors:  Craig A Portell; John W Sweetenham
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

9.  Systemic to pulmonary venous communication in the superior vena caval syndrome.

Authors:  E S Wilson
Journal:  AJR Am J Roentgenol       Date:  1976-08       Impact factor: 3.959

10.  Lymphoblastic lymphoma: a clinicopathologic study of 95 patients.

Authors:  B N Nathwani; L W Diamond; C D Winberg; H Kim; R M Bearman; J H Glick; S E Jones; R A Gams; N I Nissen; H Rappaport
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.